» Articles » PMID: 35758263

Neurofilament Light-associated Connectivity in Young-adult Huntington's Disease is Related to Neuronal Genes

Abstract

Upregulation of functional network connectivity in the presence of structural degeneration is seen in the premanifest stages of Huntington's disease (preHD) 10-15 years from clinical diagnosis. However, whether widespread network connectivity changes are seen in gene carriers much further from onset has yet to be explored. We characterized functional network connectivity throughout the brain and related it to a measure of disease pathology burden (CSF neurofilament light, NfL) and measures of structural connectivity in asymptomatic gene carriers, on average 24 years from onset. We related these measurements to estimates of cortical and subcortical gene expression. We found no overall differences in functional (or structural) connectivity anywhere in the brain comparing control and preHD participants. However, increased functional connectivity, particularly between posterior cortical areas, correlated with increasing CSF NfL level in preHD participants. Using the Allen Human Brain Atlas and expression-weighted cell-type enrichment analysis, we demonstrated that this functional connectivity upregulation occurred in cortical regions associated with regional expression of genes specific to neuronal cells. This relationship was validated using single-nucleus RNAseq data from post-mortem Huntington's disease and control brains showing enrichment of neuronal-specific genes that are differentially expressed in Huntington's disease. Functional brain networks in asymptomatic preHD gene carriers very far from disease onset show evidence of upregulated connectivity correlating with increased disease burden. These changes occur among brain areas that show regional expression of genes specific to neuronal GABAergic and glutamatergic cells.

Citing Articles

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight.

Vogel J, Corriveau-Lecavalier N, Franzmeier N, Pereira J, Brown J, Maass A Nat Rev Neurosci. 2023; 24(10):620-639.

PMID: 37620599 DOI: 10.1038/s41583-023-00731-8.


Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration.

Estevez-Fraga C, Altmann A, Parker C, Scahill R, Costa B, Chen Z Brain. 2023; 146(11):4532-4546.

PMID: 37587097 PMC: 10629790. DOI: 10.1093/brain/awad275.


The 2022 Lady Estelle Wolfson lectureship on neurofilaments.

Petzold A J Neurochem. 2022; 163(3):179-219.

PMID: 35950263 PMC: 9826399. DOI: 10.1111/jnc.15682.

References
1.
Johnson E, Gregory S . Huntington's disease: Brain imaging in Huntington's disease. Prog Mol Biol Transl Sci. 2019; 165:321-369. DOI: 10.1016/bs.pmbts.2019.04.004. View

2.
Gregory S, Crawford H, Seunarine K, Leavitt B, Durr A, Roos R . Natural biological variation of white matter microstructure is accentuated in Huntington's disease. Hum Brain Mapp. 2018; 39(9):3516-3527. PMC: 6099203. DOI: 10.1002/hbm.24191. View

3.
Whitaker K, Vertes P, Romero-Garcia R, Vasa F, Moutoussis M, Prabhu G . Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome. Proc Natl Acad Sci U S A. 2016; 113(32):9105-10. PMC: 4987797. DOI: 10.1073/pnas.1601745113. View

4.
Thu D, Oorschot D, Tippett L, Nana A, Hogg V, Synek B . Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain. 2010; 133(Pt 4):1094-110. DOI: 10.1093/brain/awq047. View

5.
Wolf R, Sambataro F, Vasic N, Wolf N, Thomann P, Saft C . Default-mode network changes in preclinical Huntington's disease. Exp Neurol. 2012; 237(1):191-8. DOI: 10.1016/j.expneurol.2012.06.014. View